During ENDO 2026 in Chicago, the Endocrine Society will release its latest treatment recommendations, “Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline.” Attendees are encouraged to arrive early at Room W375C at McCormick Place on Saturday June 13 at 4:30 p.m., for this highly anticipated session. At ENDO 2025 in San Francisco, researchers...
Zeb I. Saeed, MD, a member of the steering committee for the Endocrine Society’s Early Career Special Interest Group (SIG), shares with clinicians three patient-centric principles to treating overweight and obesity. As endocrinologists, we enter clinical practice having been well trained in the physiology and pharmacological management of obesity, what the BMI cutoffs are, and...
Last month Corcept Therapuetics Incoporated announced that the U.S. Food and Drug Administration (FDA) filed its New Drug Application (NDA) submission for the company’s proprietary, selective cortisol modulator, relacorilant, to treat patients with endogenous hypercortisolism (Cushing’s syndrome). Corcept’s NDA is based on positive results from the pivotal GRACE trial and confirmatory evidence from the Phase 3 GRADIENT...
Priyanka Majety, MD, discusses a new, FDA-approved wearable insulin-delivery patch that could potentially improve patients’ insulin adherence as well as their quality of life. Last summer, a wearable patch designed for mealtime insulin delivery (in lieu of traditional injections) received clearance from the U.S. Food and Drug Administration, extending the patch’s wear time from three...
Last month, The Journal of Clinical Endocrinology and Metabolism published a classic congenital adrenal hyperplasia (CAH)-focused supplement, titled “Challenges and Opportunities in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Throughout the Lifetime.” The supplement contains eight review articles that provide a comprehensive look at the clinical, psychosocial, treatment-related and day-to-day challenges...
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density. At the beginning of 2024, the U.S. Food and Drug...
Michael Morkos, MD, shares his recommendations for managing patients and their data as efficiently and stress-free as possible. He says that a few simple changes can make your day at the office run a lot easier and might even reduce the threat of burnout! The patient encounter is the core of clinical physician practices. That’s...
During ENDO 2026 in Chicago, the Endocrine Society will release its latest treatment recommendations, “Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline.” Attendees are encouraged to arrive early at Room W375C at McCormick Place on Saturday June 13 at 4:30 p.m., for this highly anticipated session. At ENDO 2025 in San Francisco, researchers...
